Latest cardiovascular and metabolic research news

Latest cardiovascular and metabolic research news

InnoSer offers a selection of gold standard cardio-metabolic disease models in rodents, supporting custom studies to optimize the preclinical development of your drug candidates. Learn more about you can leverage InnoSer’s experience and expertise in the...
PK/PD and Tolerability Testing in the ADPKD Mouse Model

PK/PD and Tolerability Testing in the ADPKD Mouse Model

The lead optimisation phase is a crucial process during which you investigate and select the most promising preclinical candidate(s) to progress to efficacy testing using animal models of human diseases. Pharmacokinetic (PK) and Pharmacodynamic (PD) profiling helps...
In vivo Tumorigenicity Testing to Evaluate Your Therapeutics’ Safety

Getting the Most out of Bioluminescent Imaging for Your Research

The application of bioluminescence imaging (BLI) in preclinical research studies offers quantitative, sensitive, longitudinal real-time data and can be applied in:  Validation of cancer cell lines, helping to establish improved preclinical cancer mouse models. ...
PK/PD and Tolerability Testing in the ADPKD Mouse Model

The Application of Cystic Index in the ADPKD Mouse Model 

The kidneys of autosomal dominant polycystic kidney disease (ADPKD) patients progressively enlarge due to the formation and expansion of fluid-filled cysts. However, currently there is no available therapy for ADPKD patients that targets the growth of cysts,...